Lenalidomide plus rituximab produces durable responses in mantle cell lymphoma patients
The drug combination rituximab plus lenalidomide has been found to be effective and produced long-term responses in patients with mantle cell lymphoma, scientists report.
Source: ScienceDaily Headlines - Category: Science Source Type: news